Somatic INK4a-ARF locus mutations: A significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck

Molecular Carcinogenesis

Volumn 30, Issue 1, 2001, Pages 26-36

  Poi, Ming J ^a   Yen, Thomas ^a   Li, Junan ^a   Song, Huijuan ^a   Lang, Jas C ^a   Schuller, David E ^a   Pearl, Dennis K ^b   Casto, Bruce C ^a   Tsai, Ming Daw ^a   Weghorst, Christopher M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

p14ARF; p16; Point mutations; Single stranded conformation polymorphism

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; GENE PRODUCT; MUTANT PROTEIN; PROTEIN INK4A; PROTEIN P14; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CHROMOSOME 9P; CONTROLLED STUDY; GENE INACTIVATION; GENE LOCUS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; HEAD AND NECK NEOPLASMS; HELMINTH PROTEINS; HUMANS; MUSCLE PROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

MAMMALIA;

EID: 0035145687     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200101)30:1<26::AID-MC1010>3.0.CO;2-E     Document Type: Article

References (57)

1. Cancer statistics, 1999
2. Global cancer statistics
3. The effects of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx
4. Cancer of the head and neck
5. Treatment of cancer of the head and neck
6. Frequent p53 mutations in head and neck cancer
7. The incidence of p53 mutations increases with progression of head and neck cancer
8. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck
9. Oncogene amplification in squamous cell carcinoma of the oral cavity
10. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
11. A PRAD-1/cyclin D1 gene amplification correlates with messenger RNA over-expression and tumor progression in human laryngeal carcinomas
12. A cell cycle regulator potentially involved in genesis of many tumor types
13. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
14. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
15. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
16. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
17. The ARF/p53 pathway
18. Frequent mutation of p16 in squamous cell carcinoma of the head and neck
19. ink4 mutations and altered expression in human tumors and cell lines
20. p16 gene in uncultured tumours
21. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines
22. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
23. Homozygous deletion of the multiple tumor suppressor gene 1 in the progression of human astrocytomas
24. Deletion of p16 and p15 genes in brain tumors
25. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck
26. Hypermethylation of the p16 gene in nasopharyngeal carcinoma
27. Cancer-associated mis-sense and deletion mutations impair p161NK4 CDK inhibitory activity
28. 5′ CpG island methylation is associated with transcriptional silencing of the turnout suppressor p16/cdkn2/mts1 in human cancers
29. Germline p16 mutations in familial melanoma
30. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
31. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
32. Deletion and mutation analysis of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas
33. Frequent somatic mutations of the MTS1/CDK41 (multiple tumor suppressor gene 1/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma
34. The MTS1 gene is frequently mutated in primary human esophageal tumors
35. Rates of p16 (MTS1) mutations in primary tumors with 9p loss
36. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumor of the head and neck
37. Mutational state of p16/CDKN2 and VHL genes in squamous-cell carcinoma of the oral cavity
38. The p16INK4alpha/p19ARF gene mutations are infrequent and are mutually exclusive to p53 mutations in Indian oral squamous cell carcinomas
39. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy
40. "Cold SSCP": A simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses
41. K-ras activation occurs frequently in mucinous adenocarcinoma and rarely in other common epithelial tumors of the human ovary
42. Absence of p16/MTS1 gene mutations in human prostate cancer
43. The "megaprimer" method of site-directed mutagenesis
44. INK4A: Determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4
45. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma
46. Deletion and mutational inactivation of the cyclin-dependent kinase-4 inhibitor gene (p16) in oral carcinoma
47. MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma
48. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines
49. Recognition of DNA alterations by the mismatch repair system
50. INK4A
51. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A
52. Structural basis for inhibition of the cyclin-dependent kinase Cdk 6 by the tumor suppressor p16INK4a
53. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to brock nuclear export of MDM2 and p53
54. Defective folding of p16(INK4) proteins encoded by tumor-derived alleles
55. ARF, which confers selection in mouse lung tumorigenesis
56. Tumor spectrum in ARF-deficient mice
57. Role of the INK4a locus in tumor suppression and cell mortality